| Company Name: |
LGC Science (Shanghai) Ltd.
|
| Tel: |
17717235263 |
| Email: |
fan.yang@lgcgroup.com |
| Products Intro: |
Product Name:19-Nor-5-androstene-3b,17b-diol (1 mg/ml in Acetonitrile)
CAS:25975-59-1
Purity:具体纯度，见COA Package:mg,g级，具体规格可咨询，可定制包装
|
| Company Name: |
Absin Bioscience Inc.
|
| Tel: |
021-38015121-8802 |
| Email: |
chenjw@absin.cn |
| Products Intro: |
CAS:25975-59-1
|
| Company Name: |
Toronto Research Chemicals
|
| Tel: |
+1 (416) 665-9696 |
| Email: |
info@trc-canada.com |
| Products Intro: |
CAS:25975-59-1
Package:150USD/50mg;1200USD/500mg
|
|
| | 5-ANDROSTENEDIOL Basic information |
| Product Name: | 5-ANDROSTENEDIOL | | Synonyms: | ANDROSTENEDIOL, 5-;(3S,8R,9S,10R,13S,14S,17S)-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17-DIOL;5-ANDROSTEN-3-BETA, 17-BETA-DIOL;5-ANDROSTENE-3BETA,17BETA-DIOL;5-ANDROSTENEDIOL;5-ANDROSTENEDIOL, 10,13-DIMETHYL-2,3,4,7,8,9,11,12,14,15,16,17-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17-DIOL;HERMAPHRODIOL;19-Nor-5(10)-androstene-3-beta-17-beta-diol | | CAS: | 25975-59-1 | | MF: | C18H28O2 | | MW: | 276.41 | | EINECS: | | | Product Categories: | Miscellaneous Biochemicals;Steroids | | Mol File: | 25975-59-1.mol |  |
| | 5-ANDROSTENEDIOL Chemical Properties |
| Melting point | 152-157 °C(Solv: ethanol, 95% (64-17-5)) | | Boiling point | 429.2±45.0 °C(Predicted) | | density | 1.14±0.1 g/cm3(Predicted) | | solubility | Chloroform (Very Slightly, Sonicated), Methanol (Slightly) | | form | Solid | | pka | 15.00±0.60(Predicted) | | color | White to Off-White |
| HS Code | 29061990 | | DEA Controlled Substances | CSCN: 4000
CSA SCH: Schedule III
NARC: No |
| | 5-ANDROSTENEDIOL Usage And Synthesis |
| Uses | 9-Nor-5-androstene-3β,17β-diol is a synthetic anabolic steroid that interacts with androgen receptors. 9-Nor-5-androstene-3β,17β-diol has been studied as a new C19-steroidal androgen receptor modulato
rs for potential treatment of prostate cancer. |
| | 5-ANDROSTENEDIOL Preparation Products And Raw materials |
|